Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Strøm

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Acta Anaesthesiologica Scandinavica|March 14, 2025
INCEPT: The Intensive Care Platform Trial-Design and protocolAnders Granholm, Morten Hylander Møller, Benjamin Skov Kaas-Hansen, et al.
Critical Care Medicine|January 6, 2025
A Core Outcome Set for Adult General ICU PatientsMaj-Brit Nørregaard Kjær, Camilla Rahbek Lysholm Bruun, Anders Granholm, et al.
Acta Anaesthesiologica Scandinavica|August 12, 2020
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis planMarie Warrer Petersen, Tine Sylvest Meyhoff, Marie Helleberg, et al.
Critical Care Medicine|March 4, 2025
A Core Outcome Set for Adult General ICU PatientsMaj-Brit Nørregaard Kjær, Camilla Rahbek Lysholm Bruun, Anders Granholm, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis planM W Munch, Anders Granholm, S N Myatra, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysisAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|April 1, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemiaAnders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, et al.
Acta Anaesthesiologica Scandinavica|June 16, 2026
Developing a Core Outcome Measurement Set for Adult ICU Patients, the CoreMS-ICU-A ProtocolMaj-Brit Nørregaard Kjær, Camilla Rahbek Lysholm Bruun, Camilla Bekker Mortensen, et al.
Acta Anaesthesiologica Scandinavica|June 17, 2021
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trialMarie Warrer Munch, Tine Sylvest Meyhoff, Marie Helleberg, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Acta Anaesthesiologica Scandinavica|March 14, 2025
INCEPT: The Intensive Care Platform Trial-Design and protocolAnders Granholm, Morten Hylander Møller, Benjamin Skov Kaas-Hansen, et al.
Critical Care Medicine|January 6, 2025
A Core Outcome Set for Adult General ICU PatientsMaj-Brit Nørregaard Kjær, Camilla Rahbek Lysholm Bruun, Anders Granholm, et al.
Acta Anaesthesiologica Scandinavica|August 12, 2020
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis planMarie Warrer Petersen, Tine Sylvest Meyhoff, Marie Helleberg, et al.
Critical Care Medicine|March 4, 2025
A Core Outcome Set for Adult General ICU PatientsMaj-Brit Nørregaard Kjær, Camilla Rahbek Lysholm Bruun, Anders Granholm, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis planM W Munch, Anders Granholm, S N Myatra, et al.
Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysisAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.
Intensive Care Medicine|April 1, 2022
Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemiaAnders Granholm, Maj-Brit Nørregaard Kjær, Marie Warrer Munch, et al.
Acta Anaesthesiologica Scandinavica|June 16, 2026
Developing a Core Outcome Measurement Set for Adult ICU Patients, the CoreMS-ICU-A ProtocolMaj-Brit Nørregaard Kjær, Camilla Rahbek Lysholm Bruun, Camilla Bekker Mortensen, et al.
Acta Anaesthesiologica Scandinavica|June 17, 2021
Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trialMarie Warrer Munch, Tine Sylvest Meyhoff, Marie Helleberg, et al.
Pageof 7